What Is GMP? Good Manufacturing Practice, Explained Simply

GMP stands for Good Manufacturing Practice, and it is a rulebook about how a product is made rather than a test of what comes out at the end. It covers the people, the buildings, the equipment, the ingredients and the paperwork, all arranged so that quality is built into every step of making something instead of being checked for once it is finished.

The three letters turn up on labels, supplier listings and regulator pages, usually with no explanation. This article explains what they stand for, why the rules exist, who writes and enforces them, and what phrases like cGMP and GMP-certified do and do not tell you. It also explains why research-use-only material sits outside the system altogether. It is a definition, not a judgement on any product.

What the three letters stand for

Good Manufacturing Practice is a plain description of a plain idea: make things in a way that is reliably good. The World Health Organization describes it as the part of quality assurance that ensures medicinal products are consistently produced and controlled to the quality standards appropriate to their intended use 2. The word that does the work there is consistently. GMP is not about making one excellent batch. It is about making every batch the same way, on purpose, and being able to prove it.

Quality assurance, a term worth defining, means everything you do in advance and throughout to make sure the result will be right. Quality control, its narrower cousin, means the testing you do on samples. GMP sits across both, but its centre of gravity is the first one. It is mostly about how a place is run.

Picture a restaurant kitchen. In one version there are written recipes, hand-washing rules, labelled shelves, a fridge temperature log, and a logbook entry for every batch of soup: who made it, from which ingredients, on which day. In another version a talented cook simply makes the soup and tastes it before it goes out. The second kitchen might produce lovely soup. But only the first can show you how it was made, and only the first can work out what went wrong if someone gets ill. GMP is the first kitchen, written down and made compulsory.

Why testing the finished product is not enough

The obvious way to make sure a medicine is good would be to test it before it leaves the factory. Testing is part of GMP, and it matters. But the US Food and Drug Administration states plainly that testing alone is not adequate to ensure quality 1.

There are two reasons. The first is arithmetic. In most cases only a small sample of a batch is tested, so that most of the batch can be used rather than destroyed by testing. The agency's own example is a manufacturer testing 100 tablets from a batch that contains 2 million 1. A problem that affects only some of the units, or one corner of a batch, can slip past a sample that happens not to contain it.

The second reason is that many problems cannot be seen in the product at all. The same source notes that a person usually cannot tell by smell, touch or sight whether a drug is safe or will work 1. A mix-up between two similar-looking materials, or a contamination that was invisible, can only be prevented before the fact, by how the work is organised.

So the guiding idea is that quality is built into the design and the process at every step, and the final tests are a safety net rather than the whole structure 1. Think of a car's brakes: nobody trusts them because every car is crash-tested, but because the design is sound, the factory is controlled, and a sample is checked along the way.

What a GMP factory actually has to do

The detailed rules run to hundreds of pages, but they gather around a handful of ideas. The US description lists them in one sentence: a strong quality management system, appropriate quality raw materials, robust operating procedures, detection and investigation of quality problems, and reliable testing laboratories 1. The international guide for the manufacture of the active ingredients that go into medicines fills in the detail 4.

One principle is independence. That guide requires a quality unit that is separate from production, with the authority to approve or reject 4. The group making the product is not the group deciding whether it passes. Another is that materials are not released or used until the quality unit has evaluated them, unless a controlled system allows otherwise 4. A third is that materials are bought against an agreed specification from suppliers the quality unit has approved 4.

And running through everything is writing it down. Batch records, laboratory results and any departures from the plan are documented, signed and independently reviewed, and the batch record is reviewed before a batch is released, including any deviation or out-of-specification investigation 4. A deviation, in this vocabulary, is anything that did not go according to the written procedure. Out of specification means a test result that fell outside its allowed range.

Who writes and enforces the rules: FDA, EMA, WHO

GMP is not one global law. It is a family of closely related rules written by different bodies, and it helps to know which does what.

In the United States, the Food and Drug Administration enforces its Current Good Manufacturing Practice regulations for human pharmaceuticals. It inspects manufacturing facilities worldwide, including those making active ingredients as well as finished products 1. If a company is not complying, the law treats any drug it makes as adulterated. The agency is careful to say that this label does not mean there is necessarily something wrong with the drug itself. It means the drug was not made under conditions that comply with the rules 1.

In the European Union, the European Medicines Agency describes GMP as the minimum standard a medicines manufacturer must meet in its production processes, and coordinates inspections to verify compliance and to harmonise practice across member states 3. In practice national authorities carry out most inspections, while the agency coordinates.

The World Health Organization does not enforce anything on a factory, but it publishes model GMP guidance. Its first draft text was adopted in 1968, and more than 100 countries have built the WHO provisions into their national medicines laws, with many more using its approach in writing their own 2. The International Council for Harmonisation, a body bringing regulators and industry together, publishes the guide for active ingredients used in the references here 4. Because these texts are so alike, a factory built to one set can usually be understood by an inspector from another.

What cGMP and GMP-certified do and do not mean

Two phrases cause most of the confusion. The first is cGMP. The lowercase c stands for current. The US regulator explains that it requires companies to use technologies and systems that are up to date, because equipment that was top of the line a decade or two ago may be inadequate by today's standards 1. The World Health Organization treats GMP and cGMP as the same thing 2. So cGMP is not a premium grade sitting above plain GMP. It is the same idea with a reminder that the bar moves.

One more point from the same source is easy to miss: the requirements are described as minimum requirements, and many manufacturers go beyond them 1. GMP is a floor, not a ceiling.

The second phrase is GMP-certified. Be careful with it. Regulators carry out inspections and, in Europe, record the outcome in a shared system; but there is no single worldwide GMP certificate, and the phrase is used loosely. It can mean a regulator inspected the site and found it compliant. It can mean a private auditor was paid to assess it. It can also simply mean the company says it follows the rules.

GMP and research-use-only material: two different worlds

GMP, as the regulators write it, is the rulebook for making medicines. The international guide for active ingredients says in its scope that it applies to the manufacture of active ingredients for use in human drug products 4. A medicine, in the legal sense, is something authorised for use in people, and the whole structure of inspection and authorisation hangs on that purpose.

Research-use-only material is made for a different purpose. It is sold for laboratory work and is explicitly not intended for human use, which is what the label means. A fuller explanation of that phrase is in a companion article on this site. Because it is not a medicine and has not been assessed by a medicines regulator, the medicines GMP regime is not the framework it is made under.

That does not mean such material is made carelessly, and it does not mean the opposite. It means the rulebook is simply not the same one. Some makers choose to follow a quality system voluntarily, such as a general quality-management standard, or to follow GMP-style habits of record-keeping. Nobody outside the company is required to inspect them. The honest summary is that GMP is neither required nor automatically present, and any statement about it needs to be read as a claim to be examined rather than a guarantee.

There is also a subtle wording trap. A sentence such as made in a GMP facility says something about a building. It does not say that the material is a medicine, that it has been authorised, or that a given batch was released under a medicines quality system. Those are three separate things.

How to think about it when you read a label

Keep the two kitchens in mind. GMP tells you about the kitchen: how it is run, whether there are written recipes, whether anyone independent can stop a batch, whether every step leaves a record. It does not taste the soup for you, and it does not tell you what the soup is for.

That is why GMP and the other documents in this series answer different questions. A certificate of analysis reports test results for one batch. A batch number lets you trace that batch back to its records. GMP describes the system that produced both. None replaces the others.

• If you see GMP, ask who inspected, what was covered and when.
• If you see cGMP, read it as the same thing, with the word current as a reminder.
• If you see a claim about a building, remember it is not a claim about a batch.
• If you see research use only, remember the medicines rulebook is not the one in play.
• If a document names no regulator and no date, treat the claim as a statement of intent.

Nothing here is guidance about using any substance, and a regulator's rulebook is no statement that a particular product is safe or effective. Questions about health belong with a doctor who knows your situation.